Delta-Fly Pharma,Inc.

4598

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-07FY2027 Q1

Revenue

YoY -

Operating Income

-4.2100M JPY

YoY -17.4%

Net Income

-16.8100M JPY

YoY -5.9%

EPS

-30.2JPY

YoY +14.7%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

3億円

-2.1億円

-7.1億円

-12.2億円

-17.2億円

Rev: 3億円Op: -9.6億円NI: -9.7億円

Rev: -Op: -13.2億円NI: -13.3億円

Rev: -Op: -14億円NI: -14.3億円

Rev: -Op: -17.1億円NI: -17.2億円

Rev: -Op: -16.1億円NI: -16.3億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress-

Revenue Forecast-

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan